![Matthew Klein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew Klein
Chief Executive Officer at PTC THERAPEUTICS, INC.
Net worth: 2 M $ as of 30/06/2024
Matthew Klein active positions
Companies | Position | Start | End |
---|---|---|---|
CLEARPOINT NEURO, INC. | Director/Board Member | 16/04/2020 | - |
Independent Dir/Board Member | 16/04/2020 | - | |
PTC THERAPEUTICS, INC. | Director/Board Member | 22/03/2023 | - |
Chief Executive Officer | 22/03/2023 | - | |
President | 22/03/2023 | - | |
Chief Operating Officer | 07/01/2022 | 22/03/2023 | |
Corporate Officer/Principal | 01/10/2019 | 07/01/2022 | |
Stanford University | Corporate Officer/Principal | - | - |
PTC Therapeutics International Ltd. | Director/Board Member | - | - |
Career history of Matthew Klein
Former positions of Matthew Klein
Companies | Position | Start | End |
---|---|---|---|
BioElectron Technology Corp.
![]() BioElectron Technology Corp. Miscellaneous Commercial ServicesCommercial Services BioElectron Technology Corp. is a clinical-stage biotechnology company, which engages in the research and development of therapeutics for inherited mitochondrial disease. The company was founded in 2005 and is headquartered in Mountain View, CA. | Director/Board Member | 01/01/2018 | 01/01/2020 |
Chief Executive Officer | 01/01/2018 | 01/01/2019 | |
Chief Tech/Sci/R&D Officer | 01/01/2012 | 01/01/2019 | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Edison Pharmaceuticals, Inc.
![]() Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edison Pharmaceuticals, Inc. developed drugs to treat mitochondrial diseases. It offers EPI-743 and EPI-A0001, an orally absorbed small molecules. The company was founded by Guy Miller in 2005 and was headquartered in Mountain View, CA. | Chief Tech/Sci/R&D Officer | - | - |
Training of Matthew Klein
Yale University | Doctorate Degree |
University of Pennsylvania | Undergraduate Degree |
UW School of Public Health | Graduate Degree |
Statistics
International
United States | 10 |
Ireland | 2 |
Operational
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Sectoral
Consumer Services | 6 |
Health Technology | 4 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
CLEARPOINT NEURO, INC. | Health Technology |
PTC THERAPEUTICS, INC. | Health Technology |
Private companies | 3 |
---|---|
Edison Pharmaceuticals, Inc.
![]() Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edison Pharmaceuticals, Inc. developed drugs to treat mitochondrial diseases. It offers EPI-743 and EPI-A0001, an orally absorbed small molecules. The company was founded by Guy Miller in 2005 and was headquartered in Mountain View, CA. | Health Technology |
BioElectron Technology Corp.
![]() BioElectron Technology Corp. Miscellaneous Commercial ServicesCommercial Services BioElectron Technology Corp. is a clinical-stage biotechnology company, which engages in the research and development of therapeutics for inherited mitochondrial disease. The company was founded in 2005 and is headquartered in Mountain View, CA. | Commercial Services |
PTC Therapeutics International Ltd. |
- Stock Market
- Insiders
- Matthew Klein
- Experience